Only about 5% of rare diseases have at least one approved treatment available for affected patients. To increase the availability of care options in this therapeutic area, sponsors ...
Even if your clinical trial enrollment is on track, it is still worthwhile to invest in making recruitment the smoothest–and fastest–it can be. Optimizing your approach with deeper ...
Patient enrollment is a major bottleneck for clinical trials—but it doesn’t have to be. Many patients are willing to join clinical trials and see them as a care option. But most ...
By: Emily Jordan, director of Trial Design at OneStudyTeam and former breast cancer clinical research coordinator Hundreds of breast cancer clinical trials are recruiting patients ...
Roughly 40% of adults suffer from functional gastrointestinal (GI) disorders worldwide. However, despite the prevalence of GI conditions, clinical trials for GI treatments are ...
As of 2019, the average screen failure rate in global clinical trials stood at 36.3% across therapeutic areas. That’s nearly 2% higher than the average screen failure rate reported ...
.png?width=64&name=OST%20Transparent%20(1).png)
